This early-phase study tests a new radioactive tracer called TRDC002 to see if it can help find prostate cancer that has come back or spread. The tracer attaches to a protein (PSMA) on cancer cells and lights them up on a PET scan. Six adults with recurrent or metastatic prostate…
Phase: PHASE1 • Sponsor: C Ray Therapeutics • Aim: Diagnosis
Last updated May 05, 2026 11:56 UTC